Teachers Insurance & Annuity Association of America Purchases Shares of 140 Danaher Co. (NYSE:DHR)

Teachers Insurance & Annuity Association of America purchased a new stake in shares of Danaher Co. (NYSE:DHR) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 140 shares of the conglomerate’s stock, valued at approximately $39,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Citizens Financial Group Inc. RI grew its holdings in shares of Danaher by 3.4% in the first quarter. Citizens Financial Group Inc. RI now owns 7,949 shares of the conglomerate’s stock worth $1,985,000 after purchasing an additional 263 shares during the last quarter. Strategic Wealth Partners Ltd. grew its holdings in shares of Danaher by 17.5% in the first quarter. Strategic Wealth Partners Ltd. now owns 1,284 shares of the conglomerate’s stock worth $321,000 after purchasing an additional 191 shares during the last quarter. LRI Investments LLC bought a new position in shares of Danaher in the first quarter worth approximately $170,000. Atria Investments Inc grew its holdings in shares of Danaher by 4.5% in the first quarter. Atria Investments Inc now owns 41,301 shares of the conglomerate’s stock worth $10,311,000 after purchasing an additional 1,768 shares during the last quarter. Finally, PGGM Investments bought a new position in shares of Danaher in the first quarter worth approximately $459,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Up 1.0 %

Shares of DHR traded up $2.25 during trading hours on Thursday, hitting $238.83. The company had a trading volume of 2,271,494 shares, compared to its average volume of 2,764,883. The firm has a fifty day moving average price of $256.00 and a 200-day moving average price of $259.66. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The stock has a market capitalization of $172.50 billion, a price-to-earnings ratio of 45.59, a P/E/G ratio of 4.37 and a beta of 0.85. Danaher Co. has a 52-week low of $215.68 and a 52-week high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. Danaher’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.02 EPS. On average, equities research analysts forecast that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is 20.61%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on DHR shares. Wells Fargo & Company started coverage on shares of Danaher in a report on Tuesday, August 27th. They issued an “equal weight” rating and a $280.00 target price on the stock. StockNews.com upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Wednesday. Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a report on Thursday, October 31st. KeyCorp lifted their price target on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Finally, Raymond James cut their price target on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.